B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Eglumetad

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Eglumetad, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ly
2 shared targets
bdb
2 shared targets
bdb
3 shared targets
bdb
3 shared targets
Glutamic
3 shared targets · score 41.6
Glutamic
3 shared targets · score 44.1
Loading evidence profile...

This evidence profile for Eglumetad is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.